Post by lorna on Jun 1, 2020 7:59:32 GMT -8
FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency (SAMHSA)
- Support for ACT service recipients
- Wellness/Therapeutic Apps and Other Online Resources
- Therapy and Emotional Supports
- Technology Access
- Supervised Residential and Homelessness
- Medications
- Medically Fragile / At Risk Individuals
- Leisure/Hobby/Social Connections
- Helping Individual Access Food, Toilet Paper, Soap
- COVID-19 Education and Teaching
- Engagement of Natural Supports
- Employment and School
- Criminal justice involved clients - special considerations and supports
- Co-Occurring Substance Use
- Addressing Client Safety (includes racial disparities)
- Support for ACT Team Staff
- Information and Updates: Federal Sources
- Information and Updates: State and Local Sources
- ACT Fidelity and COVID-19 Pandemic
- Words of Encouragement
- ACT Virtual Meet-Up Notes
- General